What's breaking now, across thousands of outlets.
The DCGI has sought the cancellation of manufacturing licences for obeticholic acid (5mg and 10mg tablets), used to treat primary biliary cholangitis (PBC), following similar actions by the US FDA and the European Medicines Agency.
We haven't written up this one. Live Mint has the full story — the link below goes straight to it.
Kitson Foong berkata keputusan yang dibuat Lembaga Pengampunan Wilayah Persekutuan tidak tertakluk pada semakan kehakiman.
The White House on Friday confirmed an unprecedented meeting between leaders of the US, China and Russia has been scheduled to take place on the sidelines of the Asia-Pacific Economic Cooperation…
POLICE arrested 29,479 individuals for various commercial crimes between January and October this year, an increase of 15.88 per cent compared with 25,440 arrests recorded in the same period last…
